Ledger.Open graph →
SEC Form D · filed January 5, 2021

FOG PHARMACEUTICALS, INC

Offering
$107.0M
Sold
$23.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jeffrey A. Leerink · Cambridge, MADirectorKrishna M. Yeshwant · Cambridge, MADirectorLeon A. Chen · Cambridge, MADirectorGregory L. Verdine · Cambridge, MAExec · DirectorEdward M. Fitzgerald · Cambridge, MADirectorBarbara M. Weber · Cambridge, MADirectorWeiqing M. Zhou · Cambridge, MAExecJennifer Myung · Boulder, CODirectorBarry Gainsburg · Plantation, FLDirectorVal Dziedzic · Boulder, CODirectorAnselme Le Van · Mountain View, CAExec · DirectorDeirdre M. Cummings · San Francisco, CADirectorRodney Thompson · Boulder, COExecJihan Bowes-Little · West Hollywood, CADirectorMargaret Regalia · Englewood, COExec · DirectorKevin Morelli · Savannah, GADirectorBrent Watts · Savannah, GADirectorMagnus Hillestad · Palo Alto, CAExecSimen S. Skogsrud · Palo Alto, CADirectorAlliance Equities Corporation · Overland Park, KSDirectorChristopher Hunt · Stamford, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗